In 2018, advances in the treatment of gout flares came in the form of a new nurse-led management approach to serum urate lowering and evidence that allopurinol might have a better cardiovascular safety profile than febuxostat. However, are IL-1 beta blockers such as canakinumab the future of care for patients with gout?
机构:
Michigan State Univ, Dept Family Practice, Coll Med, E Lansing, MI 48824 USA
Westside Family Med Ctr, Kalamazoo, MI USAMichigan State Univ, Dept Family Practice, Coll Med, E Lansing, MI 48824 USA
Ruoff, Gary
JOURNAL OF FAMILY PRACTICE,
2012,
61
(06):
: S11
-
S15